Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Envista Holdings Corporation

Envista Holdings ( ($NVST) ) has shared an announcement. Envista Holdings Corporation reported the results of its 2026 Annual Meeting of Stockholde...

Envista Shareholders Back Board, Pay Practices, and Auditor

Envista Holdings (($NVST)) has held its Q1 earnings call. Read on for the main highlights of the call. Envista’s latest earnings call struck a gene...

Envista Earnings Call Highlights Growth and Margin Gains

Envista Holdings (($NVST)) has held its Q1 earnings call. Read on for the main highlights of the call. Envista Holdings’ latest earnings call struc...

Envista Holdings Signals Confidence Despite Tariff and China Risks

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Qiagen (QGEN), Perrigo Company (PRGO) and Envista Ho...

Current Quarter	$0.33	Next Quarter	$0.35
Current Year	$1.43	Next Year	$1.56
QoQ Growth	+6.1%	YoY Growth	+9.1%
3Y EPS CAGR	-42.7%	Target Price	$29.85
Consensus	Buy	Upside	+27.0%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	NVST	$23.50	+0.30%	4.64M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	NVST	$23.50	+0.3%	4.64M
3
4
5
6

NVST

NVST

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Envista Holdings Corporation Data in Excel

Get Envista Holdings Corporation Data in Excel